Back to MW Marshall Wace, LLP

VIVOVIVO

Showing 0 of 15 quarters

Position history for MWMarshall Wace, LLP's holdings in MERIDIAN BIOSCIENCE INC

As of its Q4 2022 13F, Marshall Wace held 153,227 shares of VIVO (Meridian Bioscience), worth $5.1M. Marshall Wace's 13F filings listed VIVO from Q1 2022 to Q4 2022, 4 quarterly filings.

Current Value

—

Current Shares

—

Total Value Change

$0

Total Shares Change

0

No position history available for this security.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used